Verwandte Artikel zu RNA-Based Cancer Therapeutics: Techniques, Applications...

RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis - Hardcover

 
9789819634552: RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis

EUR 14,25 für den Versand von Vereinigtes Königreich nach USA

Versandziele, Kosten & Dauer

Suchergebnisse für RNA-Based Cancer Therapeutics: Techniques, Applications...

Beispielbild für diese ISBN

Verlag: Springer, 2025
ISBN 10: 9819634555 ISBN 13: 9789819634552
Neu Hardcover

Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Zustand: New. In. Artikel-Nr. ria9789819634552_new

Verkäufer kontaktieren

Neu kaufen

EUR 234,27
Währung umrechnen
Versand: EUR 14,25
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

Anzahl: Mehr als 20 verfügbar

In den Warenkorb

Foto des Verkäufers

Narendra Kumar Sharma
ISBN 10: 9819634555 ISBN 13: 9789819634552
Neu Hardcover

Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - By consistently dedicating efforts to multi-omic and other high-throughput technologies, it is expected that RNA therapies will have a vital role in future personalized medicine approaches for cancer therapy. Within this framework, analyzing the genetic sequence of a patient's tumor would allow for the detection of crucial driver mutations or changes that cause resistance to drugs. These mutations may then be targeted with RNA therapies that are particularly designed to treat those particular variations. Recent clinical trials have shown that RNA-based therapies hold great potential for treating several illnesses. However, further investigations are required to improve the delivery materials and understand the RNA alterations linked to these groundbreaking drugs, in order to facilitate their integration into clinical practice. Ideally, these therapeutic substances would be specifically administered to the tumor cells of interest using a targeted delivery agent. In this hypothetical situation, the choice of medications for cancer patients would differ depending on the precise abnormalities detected in each person, potentially including inhibitors that target circuits known to cause resistance to treatments. However, doing a more thorough assessment of the challenges and potential benefits discussed in each chapter would enhance the capacity to critically analyze this rapidly evolving field of therapies. This book largely examines the latest developments and clinical studies related to RNA-based medications, while also examining the challenges and future possibilities linked with them. This method shows potential for greatly improving the prognosis of cancer patients. Artikel-Nr. 9789819634552

Verkäufer kontaktieren

Neu kaufen

EUR 223,11
Währung umrechnen
Versand: EUR 31,05
Von Deutschland nach USA
Versandziele, Kosten & Dauer

Anzahl: 2 verfügbar

In den Warenkorb